On the mechanism of action of doxorubicin encapsulation in nanospheres for the reversal of multidrug resistance

Cancer Chemotherapy and Pharmacology

Volumn 37, Issue 6, 1996, Pages 556-560

  Hu, Yan Ping ^a   Jarillon, Sophie ^a   Dubernet, Catherine ^b   Couvreur, Patrick ^b   Robert, Jacques ^a  

^a INSTITUT BERGONIÉ   (France)

^b UNIV PARIS SUD   (France)

Author keywords

Anthracyclines; Drug encapsulation; Multidrug resistance

Indexed keywords

AZIDOPINE; DOXORUBICIN; GLYCOPROTEIN P; NANOPARTICLE; POLY(ISOHEXYL 2 CYANOACRYLATE); POLYCARBONATE; RADIOISOTOPE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CELL CONTACT; CELL MEMBRANE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DRUG BINDING; DRUG MECHANISM; ENCAPSULATION; GLIOBLASTOMA; MONOLAYER CULTURE; MULTIDRUG RESISTANCE; NONHUMAN; PHOTOAFFINITY LABELING; PRIORITY JOURNAL; RAT;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; CELL SURVIVAL; CYANOACRYLATES; DOXORUBICIN; DRUG RESISTANCE, MULTIPLE; GLIOBLASTOMA; MICROSPHERES; RATS; TUMOR CELLS, CULTURED;

EID: 0029875854     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002800050428     Document Type: Article

References (20)

1. Bennis S, Chapey C, Couvreur P, Robert J (1994) Enhanced cytotoxicity of doxorubicin encapsulated in polyisohexylcyanoacrylate nanospheres against multidrug-resistant tumour cells in culture. Eur J Cancer 30A : 89
2. Colin de Verdière A, Dubernet C, Nemati F, Poupon MF, Puisieux F, Couvreur P (1994) Uptake of doxorubicin from loaded nanoparticles in multidrug-resistant leukemic murine cells. Cancer Chemother Pharmacol 33 : 504
3. Cuvier C, Roblot-Treupel L, Millot JM, Lizard G, Chevillard S, Manfait M, Couvreur P, Poupon MF (1992) Doxorubicin-loaded nanospheres bypass tumor cell multidrug resistance. Biochem Pharmacol 44 : 509
4. Dalton WS, Grogan TM, Meltzer PS, Scheper RJ, Salmon SE (1989) Drug resistance in multiple myeloma and non-Hodgkin's lymphoma: detection of P-glycoprotein and potential circumvention by addition of verapamil to chemotherapy. J Clin Oncol 7 : 415
5. Gabizon AA (1992) Selective tumor localization and improved therapeutic index of anthracyclines encapsulated in long-circulating liposomes. Cancer Res 52 : 891
6. Gabizon A, Shiota R, Papahadjopoulos D (1989) Pharmacokinetics and tissue distribution of doxorubicin encapsulated in stable liposomes with long circulation times. J Natl Cancer Inst 81 : 1484
7. Goldstein LJ, Galski H, Fojo A, Willingham M, Lai SL, Gazdar A, Pirker R, Green A, Crist W, Brodeur GM, Lieber M, Cossman J, Gottesman MM, Pastan I (1989) Expression of a multidrug resistance gene in human cancers. J. Natl Cancer Inst 8 : 116
8. Gottesman MM, Pastan I (1993) Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev Biochem 62 : 385
9. Huet S, Schott B, Robert J (1992) P-glycoprotein overexpression cannot explain the complete doxorubicin-resistance phenotype in rat glioblastoma cell lines. Br J Cancer 65 : 538
10. Huet S, Chapey C, Robert J (1993) Reversal of multidrug resistance by a new lipophilic cationic molecule, S9788. Comparison with 11 other MDR-modulating agents in a model of doxorubicin-resistant rat glioblastoma cells. Eur J cancer 29A : 1377
11. Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 : 680
12. Marie JP, Zittoun R, Sikic BI (1991) Multidrug resistance (MDR1) gene expression in adult acute leukemias. Correlations with treatment outcome and in vitro drug sensitivity. Blood 78 : 586
13. Rahman A, Carmichael D, Harris M, Roh JK (1986) Comparative pharmacokinetics of free doxorubicin and doxorubicin entrapped in cardiolipin liposomes. Cancer Res 46 : 2295
14. Rahman A, Husain SR, Siddiqui J, Verma M, Agresti M, Center M, Safa AR, Glazer RI (1992) Liposome-mediated modulation of multidrug resistance in human HL-60 leukemia cells. J Natl Cancer Inst 84 : 1909
15. Robert J, Gianni L (1993) Pharmacokinetics and metabolism of anthracyclines. Cancer Surv 17 : 219
16. Schott B, Bennis S, Pourquier P, Ries C, Londos-Gagliardi D, Robert J (1993) Differential overexpression of mdr1 genes in multidrug-resistant rat glioblastoma cell lines selected with doxorubicin or vincristine. Int J Cancer 55 : 115
17. Sonneveld P, Durie BGM, Lockhorst HM, Marie JP, Solbu G, Suciu S, Zittoun R, Lowenberg B, Nooter K (1992) Modulation of multidrug resistant multiple myeloma by cyclosporin. Lancet 340 : 255
18. Thierry AR, Vige D, Coughlin SS, Belli JA, Dritschilo A, Rahman A (1993) Modulation of doxorubicin resistance in multidrug resistant cells by liposomes. FASEB J 7 : 572
19. Verdun C, Couvreur P, Vranckx H, Lenaerts V, Roland M (1986) Development of a nanoparticle release formulation for human use. J Control Rel 3 : 205
20. Warren L, Jardiller JC, Malarska A, Akeli MG (1992) Increased accumulation of drugs in multidrug-resistant cells induced by liposomes. Cancer Res 52 : 3241